23andMe Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:23andMe Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011288
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
23andMe Inc (23andMe) is a biotechnology research and information provider that offers tools for health and ancestry care. The company offers raw genetic data and ancestry-related genetic reports. It offers clinical development, research and development, ancestry services, commercialization services, and information of personal ancestry, genealogy and inherited traits. 23andMe’s ancestry services comprise ancestry composition, family tree tool, DNA relatives, maternal and paternal lineages, and neanderthal percentage. The company helps individuals to understand their genetic information using DNA analysis technologies and web-based interactive tools. It caters to students, clinicians, and developers. 23andMe is headquartered in Mountain View, California, the US.

23andMe Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
23andMe Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
23andMe Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
23andMe Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
23andMe Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
23andMe Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
23andMe Inc, Medical Equipment, Deal Details 10
Venture Financing 10
23andMe Raises USD250 Million in Venture Financing 10
Freenome Raises Additional USD7 Million in Series A Financing 12
Acquisition 13
23andMe Acquires CureTogether, Healthcare IT Company 13
23andMe Inc – Key Competitors 14
23andMe Inc – Key Employees 15
23andMe Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Strategy And Business Planning 17
Feb 10, 2016: 23andMe and Celmatix Collaborate to Improve Infertility Outcomes 17
Legal and Regulatory 18
Apr 06, 2017: 23andMe Granted First FDA Authorization to Market Direct-to-Consumer Genetic Health Risk Reports 18
Government and Public Interest 19
Feb 22, 2017: Celmatix and 23andMe Announce Launch of Fertility Research Community 19
Product News 20
Apr 06, 2017: FDA allows marketing of first direct-to-consumer tests that provide genetic risk information for certain conditions 20
Jul 13, 2016: 23andMe Launches New Genotyping Services for Research 22
Other Significant Developments 23
May 03, 2017: 23andMe and German Pain Specialist Grunenthal Explore the Genetics of Pain to Help Identify New Treatments for Patients 23
Jun 16, 2016: Illumina Announces Initial Customer Orders for the Global Screening Array 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
23andMe Inc, Medical Equipment, Key Facts 2
23andMe Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
23andMe Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
23andMe Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
23andMe Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
23andMe Inc, Deals By Market, 2011 to YTD 2017 8
23andMe Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
23andMe Raises USD250 Million in Venture Financing 10
Freenome Raises Additional USD7 Million in Series A Financing 12
23andMe Acquires CureTogether, Healthcare IT Company 13
23andMe Inc, Key Competitors 14
23andMe Inc, Key Employees 15
23andMe Inc, Subsidiaries 16

★海外企業調査レポート[23andMe Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Interface Inc:企業の戦略・SWOT・財務情報
    Interface Inc - Strategy, SWOT and Corporate Finance Report Summary Interface Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • ITV plc (ITV):企業の財務・戦略的SWOT分析
    ITV plc (ITV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Nuance Communications Inc (NUAN):企業の財務・戦略的SWOT分析
    Nuance Communications Inc (NUAN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Lohmann & Rauscher GmbH & Co. KG:企業の戦略的SWOT分析
    Lohmann & Rauscher GmbH & Co. KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Karolinska University Hospital-製薬・医療分野:企業M&A・提携分析
    Summary Karolinska University Hospital (KUH), a subsidiary of Karolinska Institutet is a healthcare service provider that offers patient care, research and education programs. The hospital offers cross border medical care by referring patients or by tele medicine and health care at a distance. It of …
  • Genuine Parts Company (GPC):企業の財務・戦略的SWOT分析
    Genuine Parts Company (GPC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Promedior Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Promedior Inc (Promedior) is a clinical-stage biotechnology company that develops medicines for the treatment of fibrotic disorders. The company’s pipeline products include PRM-151 and PRM-167. PRM-151 is used in the treatment of rare systemic fibrotic diseases such as myelofibrosis and idio …
  • Chugach Electric Association, Inc.:企業の発電所・SWOT分析2018
    Chugach Electric Association, Inc. - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information o …
  • South Jersey Industries, Inc. (SJI):電力:M&Aディール及び事業提携情報
    Summary South Jersey Industries, Inc. (SJI) is an energy services holding company that sources and supplies natural gas and electricity. It develops, owns, and operates on-site energy production facilities. The company provides wholesale commodity marketing and fuel management services; and also off …
  • Eni SpA (ENI)-エネルギー分野:企業M&A・提携分析
    Summary Eni S.p.A. (Eni) is an integrated oil and gas company, which carries out oil and natural gas exploration, field development and production activities. It also involves in supply, trading and shipping of natural gas, LNG, electricity and fuels. The company manages developed and undeveloped ac …
  • Alamo Group Inc (ALG):企業の財務・戦略的SWOT分析
    Alamo Group Inc (ALG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Contact Energy Ltd (CEN):石油・ガス:M&Aディール及び事業提携情報
    Summary Contact Energy Ltd (Contact Energy) is an energy company that generates electricity and sells electricity, natural gas and liquefied petroleum gas to customers. It generates electricity from various sources of energy including thermal, hydro and geothermal sources of energy. It supplies elec …
  • Helix Resources Ltd (HLX):企業の財務・戦略的SWOT分析
    Summary Helix Resources Ltd (HRL) operates as a mining and mineral exploration company. The company carries out the business of identification, acquisition, and development of mineral properties. It explores gold, copper, zinc, uranium, nickel, and iron ore properties. HRL's projects include Colleri …
  • BB Biotech AG (BION):企業の財務・戦略的SWOT分析
    Summary BB Biotech AG (BB Biotech) is a financial service provider that offers biotechnology investments. The company invests in markets that develop new drugs and therapies for use in the treatment of autoimmune and infectious diseases, oncology disorders, cardiovascular diseases, and metabolic dis …
  • Giant Eagle, Inc.:戦略・SWOT・企業財務分析
    Giant Eagle, Inc. - Strategy, SWOT and Corporate Finance Report Summary Giant Eagle, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Bangladesh Power Development Board:電力:M&Aディール及び事業提携情報
    Summary Bangladesh Power Development Board (BPDB) is an integrated electric utility. It generates using gas, furnace, diesel, hydro, coal and solar; and imports power from India. The company operates independent power plants /SIPP, rental power plant and REB using steam turbine, gas turbine, combine …
  • Tarveda Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Tarveda Therapeutics Inc (Tarveda), formerly Blend Therapeutics Inc is a clinical stage biopharmaceutical company that discovers and develops miniaturized novel biologic drug conjugates. The company develops targeted anti-cancer medicines for advancing the treatment for solid tumors. Its pip …
  • Sa Sa International Holdings Limited (178):企業の財務・戦略的SWOT分析
    Sa Sa International Holdings Limited (178) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Oxford BioMedica Plc (OXB):製薬・医療:M&Aディール及び事業提携情報
    Summary Oxford BioMedica plc (Oxford Biomedica) is a gene and cell therapy company that focuses on developing novel treatments for serious diseases. The company along with its subsidiaries has developed LentiVector, a sector leading lentiviral vector delivery platform. It has also built a platform o …
  • EnBW Energie Baden-Wurttemberg AG (EBK):電力:M&Aディール及び事業提携情報
    Summary EnBW Energie Baden-Wurttemberg AG (EnBW) is an integrated energy company. Through its subsidiaries, the company generates, procures, transmits, and supplies electricity; and produces, transports and supplies gas. It produces electricity in coal, gas, pumped storage, and nuclear power plants. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆